EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Incremental Diagnostic Value of p16/Ki-67 Dual-Stain Immunocytochemistry in HPV-Positive Women with a Type 3 Transformation Zone: A Diagnostic Accuracy Study

Anglițoiu Alina-Elisabeta, Claudia Livia Stanga, Cristian Andrei Sarau, Daniel Milan Velimirovici, Abhinav Sharma, Victor Buciu, Doina Georgescu, Nilima Rajpal Kundnani

Life · 16.11.2026 · 16 (11) · 1941

DOI: 10.3390/life16111941 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life, online erschienen am 16.11.2026. Verfasst von Anglițoiu Alina-Elisabeta und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: In women with a type 3 transformation zone (TZ3), the squamocolumnar junction is not fully visible and endocervical disease may be missed. We assessed whether p16/Ki-67 dual-stain immunocytochemistry adds diagnostic information to HPV16/18 genotyping and liquid-based cytology.

Methods

This single-center retrospective study included 312 HPV-positive women with colposcopically confirmed TZ3 who underwent cytology, dual staining and endocervical curettage (ECC) at one visit; ECC-detected CIN2+ was the reference standard. Nested logistic models (HPV16/18 plus cytology, with and without dual stain) were compared using the change in the area under the ROC curve (ΔAUC; AUC = probability that a woman with CIN2+ has a higher predicted risk than one without), a likelihood-ratio test and bootstrap internal validation.

Results

ECC detected CIN2+ in 56 women (17.9%). Against ECC, dual-stain sensitivity was 82.1%, specificity 69.9% and negative predictive value 94.7%. Adding dual staining increased the AUC from 0.760 to 0.863 (ΔAUC 0.103, 95% CI 0.055–0.163; p < 0.001; optimism-corrected AUCs 0.751 and 0.855). Eight of ten dual-stain-negative CIN2+ cases had HPV16/18 and/or ASC-H/HSIL cytology.

Conclusions

Dual staining improved statistical discrimination for ECC-detected CIN2+ beyond genotype and cytology. This does not establish clinical benefit; the test should not be used alone to omit ECC and requires external validation.

Zitieren

APA

Alina-Elisabeta, A., Stanga, C. L., Sarau, C. A., Velimirovici, D. M., Sharma, A., Buciu, V., Georgescu, D., & Kundnani, N. R. (2026). Incremental Diagnostic Value of p16/Ki-67 Dual-Stain Immunocytochemistry in HPV-Positive Women with a Type 3 Transformation Zone: A Diagnostic Accuracy Study. Life, 16(11), 1941. https://doi.org/10.3390/life16111941

Vancouver

Alina-Elisabeta A, Stanga CL, Sarau CA, Velimirovici DM, Sharma A, Buciu V, et al. Incremental Diagnostic Value of p16/Ki-67 Dual-Stain Immunocytochemistry in HPV-Positive Women with a Type 3 Transformation Zone: A Diagnostic Accuracy Study. Life. 2026;16(11):1941. doi:10.3390/life16111941

BibTeX
@article{AlinaElisabeta2026,
  author = {Alina-Elisabeta, Anglițoiu and Stanga, Claudia Livia and Sarau, Cristian Andrei and Velimirovici, Daniel Milan and Sharma, Abhinav and Buciu, Victor and Georgescu, Doina and Kundnani, Nilima Rajpal},
  title = {Incremental Diagnostic Value of p16/Ki-67 Dual-Stain Immunocytochemistry in HPV-Positive Women with a Type 3 Transformation Zone: A Diagnostic Accuracy Study},
  journal = {Life},
  year = {2026},
  volume = {16},
  number = {11},
  pages = {1941},
  doi = {10.3390/life16111941}
}
Kostenlos starten →